NEW YORK (GenomeWeb News) – Roche and Life Technologies today announced two licensing deals granting Life Tech access to PCR technologies.
Roche is granting Life Tech an in vitro diagnostic product license to all of its PCR patents for real-time PCR and other PCR-related technology in the diagnostic field. The agreements also cover reagents and methods for using SYBR Green I technology, melting curve analysis for real-time PCR, and the rights to use high-resolution melting curve analysis technology in the diagnostics field, the two firms said.
Financial terms of the deals were not disclosed.
Roche has licensed the IP portfolio in cooperation with Idaho Technology, it said. The two firms forged a licensing deal in 2005 granting Idaho Tech access to Roche's PCR patents.
Other companies that Roche has licensed its PCR IP portfolio to, in cooperation with Idaho Tech, include Qiagen, Thermo Fisher Scientific, and Takara Bio.
Paul Brown, head of Roche Molecular Diagnostics, said in a statement, "Roche has a broad, active out-licensing program for its PCR-based intellectual property portfolio. By continuing to out-license this technology, we contribute to the development of well-validated techniques within the diagnostics field."